RecallDepth
Class III Terminated

PACLITAXEL INJECTION, USP (semisynthetic); 300 mg/50 mL; (6 mg/mL); Multiple Dose Vial;(NDC 63323-763-50); Rx Only; Manufactured for APP Pharmaceuticals, LLC; Schaumburg, IL 60173; Made in India

Company
Fresenius Kabi Usa, Llc
Recall Initiated
November 8, 2013
Posted
December 4, 2013
Recall Number
D-016-2014
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
71,129 vials
Firm Location
Lake Zurich, IL, United States

Reason for Recall

Labeling: Incorrect or Missing Package Insert- Missing text on the product insert in the "Clinical Studies" and "Specific Adverse Events" sections.

Distribution

US: Nationwide and Puerto Rico

Lot / Code Info

Lot # 871ZA00201, Exp 11/13 Lot # 871ZA00301, Exp 11/13 Lot # 871ZA00302, Exp 11/13 Lot # 871ZA00401, Exp 11/13 Lot # 871ZA00402, Exp 11/13 Lot # 872ZA00101, Exp 12/13 Lot # 872ZA00201, Exp 12/13 Lot # 872ZA00301, Exp 12/13 Lot # 872ZA00401, Exp 12/13 Lot # 872ZA00501, Exp 12/13

More recalls by Fresenius Kabi Usa, Llc

View all recalls by this company →

Other recent Class III Drug recalls